The Impact of Resistance Training on Type 2 Diabetes Patients.

Diabetes Clinical Trial

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT02413060
• Other study ID #: 42500653-9
• Status: Enrolling by invitation
• Phase: N/A
• First received: March 26, 2015
• Last updated: October 13, 2015
• Start date: March 2015
• Est. completion date: March 2016

Study information

• Verified date: October 2015
• Source: Huashan Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Science and Technology Commission of Shanghai Municipality:China
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the long-term effects of high-intensity progressive resistance training could improve glucose and lipid metabolism in chinese type 2 diabetes.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 400
• Est. completion date: March 2016
• Est. primary completion date: January 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• established type 2 diabetes

Exclusion Criteria:

• severe joint cardiovascular and respiratory system disease, uncontrolled hypertension (160/90 mmHg), severe diabetic nephropathy and neuropathy

• with severe liver and kidney dysfunction

• with mental system disease

• pregnant women or nursing mothers

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Diabetes

Intervention

Other:
• Resistance training
This training consists 4 exercises and every exercises lasts 5 seconds.

Behavioral:
• Lifestyle counselling
Lifestyle counselling mainly indicates dietary instruction.

Locations

Country	Name	City	State
China	Cao jia du community health service centre	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Huashan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HbA1c		up to six months	No